
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Metabolic Messengers: ceramides
Scott A. Summers, Bhagirath Chaurasia, William L. Holland
Nature Metabolism (2019) Vol. 1, Iss. 11, pp. 1051-1058
Open Access | Times Cited: 229
Scott A. Summers, Bhagirath Chaurasia, William L. Holland
Nature Metabolism (2019) Vol. 1, Iss. 11, pp. 1051-1058
Open Access | Times Cited: 229
Showing 1-25 of 229 citing articles:
Metabolomics and lipidomics in NAFLD: biomarkers and non-invasive diagnostic tests
Mojgan Masoodi, Amalia Gastaldelli, Tuulia Hyötyläinen, et al.
Nature Reviews Gastroenterology & Hepatology (2021) Vol. 18, Iss. 12, pp. 835-856
Closed Access | Times Cited: 314
Mojgan Masoodi, Amalia Gastaldelli, Tuulia Hyötyläinen, et al.
Nature Reviews Gastroenterology & Hepatology (2021) Vol. 18, Iss. 12, pp. 835-856
Closed Access | Times Cited: 314
Ceramides and other sphingolipids as drivers of cardiovascular disease
Ran Hee Choi, Sean M. Tatum, J. David Symons, et al.
Nature Reviews Cardiology (2021) Vol. 18, Iss. 10, pp. 701-711
Open Access | Times Cited: 261
Ran Hee Choi, Sean M. Tatum, J. David Symons, et al.
Nature Reviews Cardiology (2021) Vol. 18, Iss. 10, pp. 701-711
Open Access | Times Cited: 261
Sphingolipids produced by gut bacteria enter host metabolic pathways impacting ceramide levels
Elizabeth L. Johnson, Stacey L. Heaver, Jillian L. Waters, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 243
Elizabeth L. Johnson, Stacey L. Heaver, Jillian L. Waters, et al.
Nature Communications (2020) Vol. 11, Iss. 1
Open Access | Times Cited: 243
The crucial role and mechanism of insulin resistance in metabolic disease
Xuefei Zhao, Xuedong An, Cunqing Yang, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 216
Xuefei Zhao, Xuedong An, Cunqing Yang, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 216
Ceramides in Metabolism: Key Lipotoxic Players
Bhagirath Chaurasia, Scott A. Summers
Annual Review of Physiology (2020) Vol. 83, Iss. 1, pp. 303-330
Open Access | Times Cited: 208
Bhagirath Chaurasia, Scott A. Summers
Annual Review of Physiology (2020) Vol. 83, Iss. 1, pp. 303-330
Open Access | Times Cited: 208
Machine learning reveals serum sphingolipids as cholesterol-independent biomarkers of coronary artery disease
Annelise M. Poss, J. Alan Maschek, James E. Cox, et al.
Journal of Clinical Investigation (2019) Vol. 130, Iss. 3, pp. 1363-1376
Open Access | Times Cited: 190
Annelise M. Poss, J. Alan Maschek, James E. Cox, et al.
Journal of Clinical Investigation (2019) Vol. 130, Iss. 3, pp. 1363-1376
Open Access | Times Cited: 190
Sphingolipids in metabolic disease: The good, the bad, and the unknown
Christopher D. Green, Michael Maceyka, L. Ashley Cowart, et al.
Cell Metabolism (2021) Vol. 33, Iss. 7, pp. 1293-1306
Open Access | Times Cited: 190
Christopher D. Green, Michael Maceyka, L. Ashley Cowart, et al.
Cell Metabolism (2021) Vol. 33, Iss. 7, pp. 1293-1306
Open Access | Times Cited: 190
Hyodeoxycholic acid alleviates non-alcoholic fatty liver disease through modulating the gut-liver axis
Junliang Kuang, Jieyi Wang, Yitao Li, et al.
Cell Metabolism (2023) Vol. 35, Iss. 10, pp. 1752-1766.e8
Open Access | Times Cited: 125
Junliang Kuang, Jieyi Wang, Yitao Li, et al.
Cell Metabolism (2023) Vol. 35, Iss. 10, pp. 1752-1766.e8
Open Access | Times Cited: 125
Regulation of cellular and systemic sphingolipid homeostasis
Andrew Kuo, Timothy Hla
Nature Reviews Molecular Cell Biology (2024) Vol. 25, Iss. 10, pp. 802-821
Closed Access | Times Cited: 19
Andrew Kuo, Timothy Hla
Nature Reviews Molecular Cell Biology (2024) Vol. 25, Iss. 10, pp. 802-821
Closed Access | Times Cited: 19
Roles and therapeutic targeting of ceramide metabolism in cancer
Narendra Wajapeyee, Teresa Beamon, Romi Gupta
Molecular Metabolism (2024) Vol. 83, pp. 101936-101936
Open Access | Times Cited: 17
Narendra Wajapeyee, Teresa Beamon, Romi Gupta
Molecular Metabolism (2024) Vol. 83, pp. 101936-101936
Open Access | Times Cited: 17
Lactate homeostasis is maintained through regulation of glycolysis and lipolysis
Won Dong Lee, Daniel Weilandt, Lingfan Liang, et al.
Cell Metabolism (2025)
Closed Access | Times Cited: 2
Won Dong Lee, Daniel Weilandt, Lingfan Liang, et al.
Cell Metabolism (2025)
Closed Access | Times Cited: 2
Sphingolipid metabolites involved in the pathogenesis of atherosclerosis: perspectives on sphingolipids in atherosclerosis
Fufangyu Zhao, Mingyan Shao, Mingrui Li, et al.
Cellular & Molecular Biology Letters (2025) Vol. 30, Iss. 1
Open Access | Times Cited: 2
Fufangyu Zhao, Mingyan Shao, Mingrui Li, et al.
Cellular & Molecular Biology Letters (2025) Vol. 30, Iss. 1
Open Access | Times Cited: 2
AdipoAtlas: A reference lipidome for human white adipose tissue
Mike Lange, Georgia Angelidou, Zhixu Ni, et al.
Cell Reports Medicine (2021) Vol. 2, Iss. 10, pp. 100407-100407
Open Access | Times Cited: 100
Mike Lange, Georgia Angelidou, Zhixu Ni, et al.
Cell Reports Medicine (2021) Vol. 2, Iss. 10, pp. 100407-100407
Open Access | Times Cited: 100
Ceramides in Skin Health and Disease: An Update
Yoshikazu Uchida, Kyungho Park
American Journal of Clinical Dermatology (2021) Vol. 22, Iss. 6, pp. 853-866
Closed Access | Times Cited: 91
Yoshikazu Uchida, Kyungho Park
American Journal of Clinical Dermatology (2021) Vol. 22, Iss. 6, pp. 853-866
Closed Access | Times Cited: 91
Comprehensive Circulatory Metabolomics in ME/CFS Reveals Disrupted Metabolism of Acyl Lipids and Steroids
Arnaud Germain, Dinesh Kumar Barupal, Susan Levine, et al.
Metabolites (2020) Vol. 10, Iss. 1, pp. 34-34
Open Access | Times Cited: 73
Arnaud Germain, Dinesh Kumar Barupal, Susan Levine, et al.
Metabolites (2020) Vol. 10, Iss. 1, pp. 34-34
Open Access | Times Cited: 73
Roles of Ceramides in Non-Alcoholic Fatty Liver Disease
Éric Hajduch, Floriane Lachkar, Pascal Ferré, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 4, pp. 792-792
Open Access | Times Cited: 72
Éric Hajduch, Floriane Lachkar, Pascal Ferré, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 4, pp. 792-792
Open Access | Times Cited: 72
Prosaposin mediates inflammation in atherosclerosis
Mandy M. T. van Leent, Thijs J. Beldman, Yohana C. Toner, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 584
Open Access | Times Cited: 67
Mandy M. T. van Leent, Thijs J. Beldman, Yohana C. Toner, et al.
Science Translational Medicine (2021) Vol. 13, Iss. 584
Open Access | Times Cited: 67
Host hepatic metabolism is modulated by gut microbiota-derived sphingolipids
Henry H. Le, Min-Ting Lee, Kevin R. Besler, et al.
Cell Host & Microbe (2022) Vol. 30, Iss. 6, pp. 798-808.e7
Open Access | Times Cited: 62
Henry H. Le, Min-Ting Lee, Kevin R. Besler, et al.
Cell Host & Microbe (2022) Vol. 30, Iss. 6, pp. 798-808.e7
Open Access | Times Cited: 62
Genome–microbiome interplay provides insight into the determinants of the human blood metabolome
Christian Diener, Chengzhen L. Dai, Tomasz Wilmanski, et al.
Nature Metabolism (2022) Vol. 4, Iss. 11, pp. 1560-1572
Open Access | Times Cited: 62
Christian Diener, Chengzhen L. Dai, Tomasz Wilmanski, et al.
Nature Metabolism (2022) Vol. 4, Iss. 11, pp. 1560-1572
Open Access | Times Cited: 62
Contribution of specific ceramides to obesity-associated metabolic diseases
Philipp Hammerschmidt, Jens C. Brüning
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 8
Open Access | Times Cited: 59
Philipp Hammerschmidt, Jens C. Brüning
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 8
Open Access | Times Cited: 59
The Molecular Brakes of Adipose Tissue Lipolysis
Yongguo Li, Zhen Li, Devi Anggraini Ngandiri, et al.
Frontiers in Physiology (2022) Vol. 13
Open Access | Times Cited: 51
Yongguo Li, Zhen Li, Devi Anggraini Ngandiri, et al.
Frontiers in Physiology (2022) Vol. 13
Open Access | Times Cited: 51
Dihydroceramide- and ceramide-profiling provides insights into human cardiometabolic disease etiology
Clemens Wittenbecher, Rafael R. C. Cuadrat, Luke Johnston, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 41
Clemens Wittenbecher, Rafael R. C. Cuadrat, Luke Johnston, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 41
Modified Lipoproteins Induce Arterial Wall Inflammation During Atherogenesis
Martina B. Lorey, Katariina Öörni, Petri T. Kovanen
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 40
Martina B. Lorey, Katariina Öörni, Petri T. Kovanen
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 40
Inhibiting de novo ceramide synthesis restores mitochondrial and protein homeostasis in muscle aging
Tanes Lima, Pirkka‐Pekka Laurila, Martin Wohlwend, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 696
Closed Access | Times Cited: 32
Tanes Lima, Pirkka‐Pekka Laurila, Martin Wohlwend, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 696
Closed Access | Times Cited: 32
Sphingolipids and Atherosclerosis: The Dual Role of Ceramide and Sphingosine-1-Phosphate
Marco Piccoli, Federica Cirillo, Andrea Ghiroldi, et al.
Antioxidants (2023) Vol. 12, Iss. 1, pp. 143-143
Open Access | Times Cited: 26
Marco Piccoli, Federica Cirillo, Andrea Ghiroldi, et al.
Antioxidants (2023) Vol. 12, Iss. 1, pp. 143-143
Open Access | Times Cited: 26